NCT03115333: An ongoing trial by ECOG-ACRIN Cancer Research Group
This trial is ongoing. It must report results 7 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03115333 |
|---|---|
| Title | Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 25, 2017 |
| Completion date | Dec. 31, 2025 |
| Required reporting date | Dec. 31, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 15, 2026 |
| Days late | None |